Pfizer has raised its 2021 sales forecast for its COVID-19 vaccine by 29 percent to $33.5 billion and said it believes people will need a third dose of the shot developed with German partner BioNTech to keep protection against the virus high.
The company said it could apply for an emergency use authorization for a booster dose as early as August.
Even without boosters, the company’s 2021 sales forecast is expected to move higher as it only accounts for 2.1 billion doses that it has committed to countries out of three billion it plans to make this year.
Readers Bureau, Contributor
Edited by Jesus Chan
Do you want to add feedback to this story?
Please add a comment in the box below or send an email to email@example.com, send us a message on WhatsApp at 646-874-7976 or Call us at 201-500-7715